The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
The pathological process underlying Alzheimer’s disease in individuals under thirty
Abstract
Brains of 42 individuals between the ages of 4 and 29 were examined with antibodies (AT8, 4G8) and silver stains for the presence of intraneuronal and extracellular protein aggregates associated with Alzheimer's disease. Thirty-eight of 42 (38/42) cases displayed abnormally phosphorylated tau protein (pretangle material) in nerve cells or in portions of their cellular processes, and 41/42 individuals showed no extracellular amyloid-β protein deposition or neuritic plaques-an individual with Down syndrome was the only exception. In 16/42 cases abnormal tau was found in the transentorhinal region, and in 3/42 cases this site was Gallyas-positive for isolated NFTs (NFT stage I). Of 26 cases that lacked abnormal tau in the transentorhinal region, 4 did not show pretangle material at subcortical sites. The remaining 22 of these same 26 cases, however, had subcortical lesions confined to non-thalamic nuclei with diffuse projections to the cerebral cortex, and, remarkably, in 19/22 individuals the pretangle material was confined to the noradrenergic coeruleus/subcoeruleus complex. Assuming the pretangle alterations are not transient and do not regress, these findings may indicate that the Alzheimer's disease-related pathological process leading to neurofibrillary tangle formation does not begin in the cerebral cortex but, rather, in select subcortical nuclei, and it may start quite early, i.e., before puberty or in early young adulthood.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recently, it has been reported that NFTs are also very common in certain brainstem nuclei in subjects without dementia (39-44).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [39]
In the citing paper
“At 40 years, all individuals studied by Braak and Del Tredici (39) and Braak et al (44) exhibited at least initial neurofibrillary pathology in the brainstem (Fig. 5).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [39]
In the citing paper
“Neurofibrillary pathology is observed in the human brain long before Aβ plaques develop (39, 44, 300).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [39]
In the citing paper
“Although some studies have interpreted phosphorylated tau abnormalities in the locus coeruleus to be an early stage of AD pathology [15], young control subjects were not screened for a history of exposure to mTBI despite the fact that mTBI is common among young individuals and that 17 % of the control subjects died from acute trauma or accidental death.”
From The neuropathology of sport (2014) · cites this paper as [15]
In the citing paper
“The focal collections of perivascular NFTs in the depths of the cortical sulci in CTE [65, 66, 126–128] differ substantially from PHF-tau pathology of the Alzheimer type reported in some cognitively normal young adults [15], opiate abusers [4], and non-demented elderly subjects such as those in the Framingham Heart Study [6] or Honolulu Asian Aging Study [67, 194].”
From The neuropathology of sport (2014) · cites this paper as [15]
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 7×
“Characteristic changes in the lesional distribution pattern are used to distinguish stages in the course of the process [1, 4, 13 , 18, 20, 51, 91].”
BackgroundMethodInfluentialSelf-citationThe Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Self-citationAlzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Aston-Jones, G., & Cohen, J. D. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.061604.135709 · Cited by 4,472
Gauthier, S. G., Reisberg, ., Zaudig, M., Petersen, R. C., Ritchie, K. A., Broich, K., Belleville, S., Brodaty, H., Bennett, D. A., Chertkow, H. M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68542-5 · Cited by 4,094
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490
Self-citationBraak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., & Del Tredici, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0127-z · Cited by 3,172
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- Braak H, Braak E, Yilmazer D, Schultz C, Bohl J (1995) Age-related changes of the human cerebral cortex. In: Cruz-Sanchez FF, Ravid R, Cuzner ML (eds) Neuropathologic diagnostic criteria for brain banking. IOS Press, Amsterdam, pp 14–19
Cited by
Sorted by citations
Items 301–400 of 813
The night’s watch: Exploring how sleep protects against neurodegeneration
Parhizkar, S., & Holtzman, D. M. (2025) · Neuron · doi:10.1016/j.neuron.2025.02.004 · Cited by 54
Peña‐Altamira, E., Petralla, S., Massenzio, F., Virgili, M., Bolognesi, M. L., & Monti, B. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00175 · Cited by 46
Koychev, I. G., Hofer, M., & FRIEDMAN, N. C. (2020) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.230458 · Cited by 52
Predicting Reduction of Cerebrospinal Fluid β-Amyloid 42 in Cognitively Healthy Controls
Mattsson, N., Insel, P. S., Donohue, M., Jagust, W., Sperling, R., Aisen, P., & Weiner, M. W. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2014.4530 · Cited by 45
Egroo, M. V., van Hooren, R. W. E., & Jacobs, H. I. L. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00902-8 · Cited by 52
Noradrenaline in Alzheimer’s Disease: A New Potential Therapeutic Target
Gutiérrez, I. L., Russo, C. D., Novellino, F., Caso, J. R., García‐Bueno, B., Leza, J. C., & Madrigal, J. L. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116143 · Cited by 53
Calderón‐Garcidueñas, L., & de la Monte, S. M. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161299 · Cited by 50
Predicted sequence of cortical tau and amyloid-β deposition in Alzheimer disease spectrum
Cho, H., Lee, H. S., Choi, J. Y., Lee, J., Ryu, Y. H., Lee, M. S., & Lyoo, C. H. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.04.007 · Cited by 45
Spiers, J. G., Chen, H. C., Bourgognon, J.-M., & Steinert, J. R. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.01.025 · Cited by 46
Delta-secretase cleavage of Tau mediates its pathology and propagation in Alzheimer’s disease
Kang, S. S., Ahn, E. H., & Ye, K. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00494-7 · Cited by 46
Caillierez, R., Bégard, S., Lécolle, K., Deramecourt, V., Zommer, N., Dujardin, S., Loyens, A., Dufour, N., Aurégan, G., Winderickx, J., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.66 · Cited by 43
Recent developments with tau-based drug discovery
Iqbal, K., Liu, F., & Gong, C. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1445084 · Cited by 46
D’Angiulli, A. (2018) · Frontiers in Public Health · doi:10.3389/fpubh.2018.00095 · Cited by 46
Santiago, J. A., Bottero, V., & Potashkin, J. A. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01273 · Cited by 43
Basal Forebrain Cholinergic Neurons: Linking Down Syndrome and Alzheimer’s Disease
Martinez, J. L., Zammit, M. D., West, N. R., Christian, B. T., & Bhattacharyya, A. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.703876 · Cited by 47
Menuet, C., Cazals, Y., Gestreau, C., Borghgraef, P., Gielis, L., Dutschmann, M., LEUVEN, F. V., & Hilaire, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025770 · Cited by 48
Jacobs, H. I. L., Becker, J. A., Kwong, K. K., Munera, D., Ramirez-Gomez, L. A., Engels, N., Sanchez, J. S., Vila‐Castelar, C., Baena, A. Y., Sperling, R. A., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12656 · Cited by 45
Misframed ubiquitin and impaired protein quality control: an early event in Alzheimer’s disease
Gentier, R. J. G., & van Leeuwen, F. W. (2015) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2015.00047 · Cited by 46
Braak, H., & Tredici, K. D. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1153-2 · Cited by 44
Self-citationMaurin, H., Chong, S., Kraev, I., Davies, H. A., Kremer, A., Seymour, C. M., Lechat, B., Jaworski, T., Borghgraef, P., Devijver, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087605 · Cited by 44
Treatment of Alzheimer’s Disease: Trazodone, Sleep, Serotonin, Norepinephrine, and Future Directions
Ashford, J. W. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181106 · Cited by 46
The common marmoset as a model of neurodegeneration
Perez‐Cruz, C., & Rodríguez-Callejas, J. D. (2023) · Trends in Neurosciences · doi:10.1016/j.tins.2023.02.002 · Cited by 39
Arendt, T., Stieler, J., & Holzer, M. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1342-8 · Cited by 46
Early Alzheimer-type lesions in cognitively normal subjects
Tsartsalis, S., Xekardaki, A., Hof, P. R., Kövari, E., & Bouras, C. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.10.002 · Cited by 41
Sánchez, S. M., Abulafia, C., Duarte-Abritta, B., Guevara, M., Castro, M. N., Drucaroff, L. J., Sevlever, G. E., Nemeroff, C. B., Vigo, D. E., Loewenstein, D., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170491 · Cited by 43
The past, present, and future of disease-modifying therapies for Alzheimer’s disease
Suzuki, K., Iwata, A., & Iwatsubo, T. (2017) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.93.048 · Cited by 42
Tau deposition in young adults with drug-resistant focal epilepsy.
Smith, K. M., Blessing, M. M., Parisi, J. E., Britton, J. W., Mandrekar, J., & Cascino, G. D. (2019) · Epilepsia · doi:10.1111/epi.16375 · Cited by 42
Corsetti, V., Borreca, A., Latina, V., Giacovazzo, G., Pignataro, A., Krashia, P., Natale, F., Cocco, S., Rinaudo, M., Malerba, F., et al. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa039 · Cited by 42
Brainstem Volumetric Integrity in Preclinical and Prodromal Alzheimer’s Disease
Dutt, S., Initiative, A. D. N., Li, Y., Mather, M., & Nation, D. A. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200187 · Cited by 46
The Prion-Like Behavior of Assembled Tau in Transgenic MicePreprint
Clavaguera, F., Tolnay, M., & Goedert, M. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024372 · Cited by 45
Chiu, M., & Fan, L. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s45143 · Cited by 41
Biophenols pharmacology against the amyloidogenic activity in Alzheimer’s disease
Omar, S. H. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.02.051 · Cited by 42
Kelly, S. C., McKay, E. C., Beck, J. S., Collier, T. J., Dorrance, A. M., & Counts, S. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190090 · Cited by 44
Mitochondrial dysfunction in neurodegenerative diseases: A focus on iPSC-derived neuronal models
Trombetta-Lima, M., Sabogal-Guáqueta, A. M., & Dolga, A. M. (2021) · Cell Calcium · doi:10.1016/j.ceca.2021.102362 · Cited by 42
Oshima, E., Ishihara, T., Yokota, O., Nakashima‐Yasuda, H., Nagao, S., Ikeda, C., Naohara, J., Terada, S., & Uchitomi, Y. (2013) · Brain Pathology · doi:10.1111/bpa.12059 · Cited by 44
Pamphlett, R., & Jew, S. K. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142445 · Cited by 42
Chronic Effects of Mild Neurotrauma: Putting the Cart Before the Horse?
Castellani, R. J., Perry, G., & Iverson, G. L. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000193 · Cited by 40
Alzheimer’s disease and sleep disorders: A bidirectional relationship
Chen, J., Peng, G., & Sun, B. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.08.008 · Cited by 45
Opattová, A., Filipčík, P., Cente, M., & Novák, M. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121072 · Cited by 41
Invited review: Drug development for tauopathies
Grüninger, F. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12192 · Cited by 40
Chapman, B. P., Huang, A., Peters, K. D., Horner, E. M., Manly, J. J., Bennett, D. A., & Lapham, S. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.3120 · Cited by 42
Locus coeruleus pathology in progressive supranuclear palsy, and its relation to disease severity
Kaalund, S. S., Passamonti, L., Allinson, K. S. J., Murley, A. G., Robbins, T. W., Spillantini, M. G., & Rowe, J. B. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-0886-0 · Cited by 48
Lu, J., Bao, W., Li, M., Li, L., Zhang, Z., Alberts, I., Brendel, M., Cumming, P. D., Lu, H., Xiao, Z., et al. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00604 · Cited by 41
Filipčík, P., Novák, P., Mravec, B., Ondičová, K., Krajciova, G., Novák, M., & Květňanský, R. (2012) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-011-9788-9 · Cited by 38
No evidence of a longitudinal association between diurnal cortisol patterns and cognition
Singh‐Manoux, A., Dugravot, A., Elbaz, A., Shipley, M. J., Mika Kivimaki, B., & Meena Kumari, B. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.03.015 · Cited by 40
Anti-dementia medications: current prescriptions in clinical practice and new agents in progress
Stella, F., Radanovic, M., Canineu, P. R., de Paula, V. D. J. R., & Forlenza, O. V. (2015) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098615592116 · Cited by 39
Stuart, K. E., King, A. E., Fernández-Martos, C. M., Dittmann, J., Summers, M. J., & Vickers, J. C. (2016) · The Journal of Comparative Neurology · doi:10.1002/cne.24156 · Cited by 39
Preventing neurodegeneration by adrenergic astroglial excitation
Zorec, R., Parpura, V., & Verkhratsky, A. (2018) · FEBS Journal · doi:10.1111/febs.14456 · Cited by 40
The VTA dopaminergic system as diagnostic and therapeutical target for Alzheimer's disease
Krashia, P., Spoleti, E., & D’Amelio, M. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1039725 · Cited by 41
The ‘a, b, c’s of pretangle tau and their relation to aging and the risk of Alzheimer’s Disease
Harley, C. W., Walling, S. G., Yuan, Q., & Martin, G. M. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.12.010 · Cited by 41
Rescue of impaired late–phase long-term depression in a tau transgenic mouse model
Ahmed, T., Blum, D. L., Burnouf, S., Demeyer, D., Buée‐Scherrer, V., D’Hooge, R., Buée, L., & Balschun, D. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.09.015 · Cited by 45
Doll, J., Thompson, R., & Sawtell, N. M. (2019) · Journal of Virology · doi:10.1128/jvi.02209-18 · Cited by 38
PIKfyve activity is required for lysosomal trafficking of tau aggregates and tau seeding
Soares, A. C., Ferreira, A., Mariën, J., Delay, C., Lee, E. B., Trojanowski, J. Q., Moechars, D., Annaert, W. G., & Muynck, L. D. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100636 · Cited by 43
Bayesian Physics-Based Modeling of Tau Propagation in Alzheimer's Disease
Schäfer, A., Peirlinck, M., Linka, K., Ellen Kuhl, A., & (ADNI), T. A. D. N. I. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.702975 · Cited by 38
The toxic metal hypothesis for neurological disorders
Pamphlett, R., & Bishop, D. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1173779 · Cited by 44
Amyloid or tau: the chicken or the egg?
Mann, D. M. A., & Hardy, J. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1162-1 · Cited by 39
Walsh, C., Drinkenburg, W. H. I. M., & Ahnaou, A. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.12.020 · Cited by 37
Quinlan, M. A. L., Strong, V., Skinner, D. M., Martin, G. M., Harley, C. W., & Walling, S. G. (2019) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2018.00067 · Cited by 38
Assessing mild cognitive impairment using object‐location memory in immersive virtual environments
Castegnaro, A., Howett, D., Li, A., Harding, E. M., Chan, D., Burgess, N., & King, J. A. (2022) · Hippocampus · doi:10.1002/hipo.23458 · Cited by 37
Neuron-Specific Alterations in Signal Transduction Pathways associated with Alzheimer's Disease
Gerschütz, A., Heinsen, H., Grünblatt, E., Wagner, A. K., Bartl, J., Meißner, C., Fallgatter, A. J., Al‐Sarraj, S., Troakes, C., Ferrer, I., et al. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131280 · Cited by 37
Korczyn, A. D. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.04.001 · Cited by 42
Evans, A. K., Defensor, E. B., & Shamloo, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1030609 · Cited by 40
Tau truncation in the pathogenesis of Alzheimer’s disease: a narrative review
Chu, D., Yang, X., Wang, J., Zhou, Y., Gu, J., Miao, J., Wu, F., & Liu, F. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.385853 · Cited by 39
The emotion paradox in the aging body and brain
Mather, M. (2024) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.15138 · Cited by 38
Tau propagation in the brain olfactory circuits is associated with smell perception changes in aging
Diez, I. P., Ortiz-Terán, L., Ng, T. S. C., Albers, M. W., Marshall, G. A., Orwig, W., Kim, C. M., Bueichekú, E., Montal, V., Olofsson, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48462-3 · Cited by 39
del Cerro, I., Martínez‐Zalacaín, I., Guinea-Izquierdo, A., Gascón‐Bayarri, J., Viñas-Díez, V., Urretavizcaya, M., Naval‐Baudin, P., Aguilera, C., Reñé‐Ramírez, R., Ferrer, I., et al. (2020) · NeuroImage Clinical · doi:10.1016/j.nicl.2020.102482 · Cited by 35
Tau in Alzheimer’s Disease: Pathological Alterations and an Attractive Therapeutic Target
Gu, J., & Liu, F. (2020) · Current Medical Science · doi:10.1007/s11596-020-2282-1 · Cited by 41
Menuet, C., Borghgraef, P., Matarazzo, V. A., Gielis, L., Lajard, A.-M., Voituron, N., Gestreau, C., Dutschmann, M., LEUVEN, F. V., & Hilaire, G. (2011) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2011.06.030 · Cited by 35
Wu, S. Z., Masurkar, A. V., & Balcer, L. J. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.572337 · Cited by 38
Streit, W. J., Rotter, J., Winter, K., Müller, W. C., Khoshbouei, H., & Bechmann, I. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215334 · Cited by 37
Tauons and Prions: Infamous Cousins?
Novák, P., Prčina, M., & Kontseková, E. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110194 · Cited by 36
Peripheral Lewy body pathology in Parkinson's disease and incidental Lewy body disease: Four cases
Tredici, K. D., & Duda, J. E. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.06.003 · Cited by 36
Mercan, D., & Heneka, M. T. (2022) · Biology · doi:10.3390/biology11121822 · Cited by 34
Walker, J. M., Goette, W. F., Farrell, K. W., Iida, M. A., Karlovich, E., The PART Working Group, White, C. L., Crary, J. F., & Richardson, T. E. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.12966 · Cited by 35
Overlaps and divergences between tauopathies and synucleinopathies: a duet of neurodegeneration
Li, W., & Li, J. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00407-y · Cited by 37
Mawanda, F., Wallace, R. B., McCoy, K. D., & Abrams, T. E. (2016) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2016.08.004 · Cited by 36
Primary Age-Related Tauopathy: An Elderly Brain Pathology Frequently Encountered during Autopsy
Kim, D., Kim, H.-S., Choi, S., Kim, B. C., Lee, M. C., Lee, K., & Lee, J.-H. (2019) · Journal of Pathology and Translational Medicine · doi:10.4132/jptm.2019.03.14 · Cited by 34
Intestinal Flora Affect Alzheimer's Disease by Regulating Endogenous Hormones
Wu, Y., Hang, Z., Tong, L., & Du, H. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03784-w · Cited by 34
Alzheimer’s disease: From basic science to precision medicine approach
Forloni, G. (2020) · BMJ Neurology Open · doi:10.1136/bmjno-2020-000079 · Cited by 33
Bermejo‐Pareja, F., & del Ser, T. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13020536 · Cited by 39
Irmler, M., Gentier, R. J. G., Dennissen, F. J. A., Schulz, H., Bolle, I., Hölter, S. M., Kallnik, M., Cheng, J. J., Klingenspor, M., Rozman, J., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1003-7 · Cited by 34
Bauer, C. M., Cabral, H., & Killiany, R. (2018) · Diagnostics · doi:10.3390/diagnostics8010014 · Cited by 32
Ferencz, B., Karlsson, S., & Kalpouzos, G. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/421452 · Cited by 35
Reply: the early pathological process in sporadic Alzheimer’s disease
Braak, H., & Tredici, K. D. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1170-1 · Cited by 36
Self-citationO’Sullivan, S., Heinsen, H., Grinberg, L. T., Chimelli, L. M. C., Amaro, E., Saldiva, P. H. N., Jeanquartier, F., Jean-Quartier, C., Martin, M. D. G. M., Sajid, M. I., et al. (2019) · Brain Informatics · doi:10.1186/s40708-019-0096-3 · Cited by 31
Kim, J., Yon, D. K., Choi, K. Y., Lee, J. J., Kim, N., Lee, K. H., & Kim, J. G. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-00978-w · Cited by 31
Evans, A. K., Park, H. H., Woods, C. E., Lam, R. K., Rijsketic, D. R., Xu, C. L., Chu, E. K., Ciari, P., Blumenfeld, S. E., Vidano, L. M., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03306-1 · Cited by 31
Dordevic, M., Müller-Fotti, A., Müller, P., Schmicker, M., Kaufmann, J., & Müller, N. G. (2017) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-170021 · Cited by 29
Shively, S. B., Priemer, D. S., Stein, M. B., & Perl, D. P. (2021) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2021.04.003 · Cited by 32
Cryo-EM structures of τ filaments from human brain
Goedert, M. (2021) · Essays in Biochemistry · doi:10.1042/ebc20210025 · Cited by 33
Tau in Late-Life Depression: A Systematic Review and Meta-Analysis
Brown, E. E., Iwata, Y., Chung, J. K., Gerretsen, P., & Graff-Guerrero, A. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-160401 · Cited by 29
Libard, S., & Alafuzoff, I. I. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0748-9 · Cited by 29
Duquette, A., Pernègre, C., Carpentier, A. V., & Leclerc, N. M. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.607680 · Cited by 38
Zhu, Z., Lu, J., Wang, S., Peng, W., Yang, Y., Chen, C., Zhou, X. J., Yang, X., Xin, W., Chen, X., et al. (2022) · Aging Cell · doi:10.1111/acel.13587 · Cited by 28
Alzheimer’s Disease: From Amyloid to Autoimmune Hypothesis
Arshavsky, Y. I. (2020) · The Neuroscientist · doi:10.1177/1073858420908189 · Cited by 28
Herrup, K. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.04.002 · Cited by 29
Sonic hedgehog signalling pathway contributes in age-related disorders and Alzheimer’s disease
Parashar, A., jha, D., Mehta, V., Chauhan, B., Ghosh, P., Deb, P. K., Jaiswal, M., & Prajapati, S. K. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102271 · Cited by 28
Arenas, F., Castro, F., Núñez, S., Gay, G., García‐Ruiz, C., & Fernández-Checa, J. C. (2020) · Aging · doi:10.18632/aging.102641 · Cited by 28
Rabaneda‐Bueno, R., Mena‐Montes, B., Torres‐Castro, S., Torres‐Carrillo, N., & Torres-Carrillo, N. M. (2021) · Genes · doi:10.3390/genes12121959 · Cited by 30
Spatial Extent of Amyloid-β Levels and Associations With Tau-PET and Cognition
Ozlen, H., Binette, A. P., Köbe, T., Meyer, P., Gonneaud, J., St‐Onge, F., Provost, K., Soucy, J., Rosa‐Neto, P., Breitner, J. C. S., et al. (2022) · JAMA Neurology · doi:10.1001/jamaneurol.2022.2442 · Cited by 28
Metadata
- Authors
- Braak, H., & Del Tredici, K.
- Affiliations
- Universität Ulm (DE)
- Corresponding author
- Braak, Heiko
- ORCID
- Braak, Heiko
- Venue
- Acta Neuropathologica
- Published
- 2010-12-15
- Volume
- 121
- Issue
- 2
- Pages
- 171-181
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W2081533023
- Cited by
- 812
- References
- 103
- Citations by year
- 2026: 42 · 2025: 43 · 2024: 58 · 2023: 39 · 2022: 55 · 2021: 74 · 2020: 61 · 2019: 52 · 2018: 51 · 2017: 41 · 2016: 57 · 2015: 52 · 2014: 55 · 2013: 49 · 2012: 45
- FWCI
- 27.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Acta Neuropathologica (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, young adults, tau phosphorylation, neurofibrillary tangles, amyloid-beta, neuritic plaques, subcortical nuclei, AT8 antibody, Down syndrome
- MeSH terms
- Adolescent, Adult, Alzheimer Disease, Brain, Child, Child, Preschool, DNA-Binding Proteins, Female, Humans, Male, Neurons, Phosphorylation, Retrospective Studies, Cohort Studies, Amyloid beta-Peptides, Neurofibrillary Tangles, tau Proteins, Ubiquitin, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
